Bio2Device Serology of COVID-19
Author: admin
How to Secure an Emergency Use Authorization (EUA) for COVID-19.
https://userwiseconsulting.com/EUA-Webinar-Slides
Raising awareness for Patient Safety in clinical trials and the commercial launch
Allogeneic Natural Killer Cells Engineered to Beat Cancer
Nanostructured Biomaterials for Therapeutic Delivery
Applying machine learning and artificial intelligence to the development of a pharmaceutical tablet
Applying machine learning and artificial intelligence to the development of a pharmaceutical tablet
The Evolving Field of Cancer Immunotherapy & Immuno-oncology
Suraj highlighted the evolution of the immuno-oncology field and the more recent advances and successes in the clinic.
Lasers? (not those from “Star Wars”) What? Why and How?
Augmented Intelligence in Life Sciences and Healthcare: What Your Data Can Show You (While You Decide What To Do)
Augmented Intelligence in Life Sciences and Healthcare: What Your Data Can Show You (While You Decide What To Do)
Gunnar Carlsson
Artificial intelligence is rapidly developing in many domains, including life sciences and health care. The broader notion of augmented intelligence, where machines interact with humans, is of a great deal of importance. Data sets in life sciences and healthcare are large and complex to the point of being beyond human comprehension.
What if you could “see” the shape of this data in its purest topological form, and interrogate it from this vantage point not achievable with conventional analysis methods? What might you find? What new discoveries might you make? And what might you do next?
Tonight’s talk from Gunnar Carlsson, mathematics Professor Emeritus at Stanford University and co-founder of Ayasdi, will feature examples of a methodology called Topological Data Analysis (TDA) applied to life sciences and healthcare data of a variety of types and sources. This approach has been developing rapidly in the last ten years, supports augmented intelligence, and does not require annotated data.
Case studies of data and derived insights for next step decision-making include:
– stratifying asthma and diabetes based on genomic and phenotypic/EMR data
– identifying optimal clinical care paths for knee replacement and bowel surgery based on variations detected in physician protocol and patient outcomes
– the progression of infectious disease
– the relationship of fMRI data with temporal information about tasks and task transitions
Attention will be given to the process used to examine the data, and how to decide what to do next.
Didn’t see your use case covered? Bring your questions. Whether you are an investigator, drug or device developer, clinician, regulatory professional, basic scientist, or other with a life sciences interest, all questions are welcome at our extended Q&A.
How to Grow Your Scientific Business from Referrals Only to Sales Ready
How to Grow Your Scientific Business from Referrals Only to Sales Ready
Bindu Joshi
CEO & Founder
Josh.i
We will be discussing business growth strategies that scientific businesses can use to grow their business from referrals only to commercial ready. Many scientific businesses are typically owned by scientists (not businessmen/women), and offer innovative, niche services/products that they’re uniquely skilled at and passionate about. We’re neither trained nor interested in learning the skills of running a business. So, over time, the demands of running the business lead to overwhelm, frustration and stress. We will discuss strategies and tactics for business growth to get out of this grind and enjoy your business success.